What Inhibrx Biosciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 3 |
| Total trades | 0 | 3 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 350,000 |
| Net activity | +0 | −350,000 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Viking Global Investors Lp | 10% owner | Oct 07 | Open-market sale · S | −25,042 | $32.25 | −$808K | 102,864 |
| Viking Global Investors Lp | 10% owner | Oct 07 | Open-market sale · S | −16,315 | $32.25 | −$526K | 67,018 |
| Viking Global Investors Lp | 10% owner | Oct 07 | Open-market sale · S | −308,643 | $32.25 | −$9.95M | 1,267,823 |
| Kayyem Jon Faiz | Director | Mar 27 | Gift · G | −90,000 | — | — | 419,360 |
| Kayyem Jon Faiz | Director | Dec 16 | Gift · G | +250,000 | — | — | 250,000 |
| Kayyem Jon Faiz | Director | Dec 16 | Gift · G | +250,000 | — | — | 250,000 |
| Kayyem Jon Faiz | Director | Dec 16 | Gift · G | −500,000 | — | — | 509,360 |
| Kayyem Jon Faiz | Director | Dec 06 | Gift · G | −52,000 | — | — | 1,009,360 |
| Kayyem Jon Faiz | Director | Nov 20 | Open-market buy · P | +18,750 | $14.19 | +$266K | 69,843 |
| Kayyem Jon Faiz | Director | Nov 20 | Open-market buy · P | +18,750 | $14.19 | +$266K | 69,843 |
| Kayyem Jon Faiz | Director | Nov 19 | Open-market buy · P | +34,843 | $14.23 | +$496K | 51,093 |
| Kayyem Jon Faiz | Director | Nov 19 | Open-market buy · P | +34,843 | $14.23 | +$496K | 51,093 |
| Vuori Kristiina Md | Director | Oct 03 | Open-market buy · P | +6,667 | $15.00 | +$100K | 20,443 |
| Lappe Mark | Chief Executive Officer | Sep 16 | Open-market buy · P | +13,037 | $17.13 | +$223K | 705,548 |
| Lappe Mark | Chief Executive Officer | Sep 12 | Open-market buy · P | +26,963 | $15.05 | +$406K | 692,511 |
| Vuori Kristiina Md | Director | Sep 11 | Open-market buy · P | +6,457 | $15.07 | +$97.3K | 13,776 |
| Lappe Mark | Chief Executive Officer | Sep 10 | Open-market buy · P | +8,500 | $15.19 | +$129K | 665,548 |
| Vuori Kristiina Md | Director | Sep 10 | Open-market buy · P | +179 | $15.00 | +$2.69K | 7,319 |
| Lappe Mark | Chief Executive Officer | Sep 09 | Open-market buy · P | +9,500 | $15.21 | +$144K | 657,048 |
| Lappe Mark | Chief Executive Officer | Sep 06 | Open-market buy · P | +26,000 | $15.29 | +$398K | 647,548 |
Loading...